Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-glutamine in sickle cell anemia and sickle ß0-thalassemia
NCT00125788Phase 2Completed
- Start
- Mar 2004
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sickle cell anemia (SCA) and sickle beta zero thalassemia (HbS/β⁰-thalassemia) comparing L-glutamine with Placebo (2 arms). Primary endpoint: Number of Occurrences of Painful Sickle Cell Crises. Started Mar 2004; status: completed.
02
Drugs
glutamine
03
Conditions
sickle cell anemia (SCA)sickle beta zero thalassemia (HbS/β⁰-thalassemia)
Beyond the preview
Go deeper on NCT00125788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125788.